The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

NCT05741944 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Soft-tissue Sarcoma
Predictive Cancer Model

Interventions

OTHER: Care with the use of PERSARC
OTHER: standard care

Sponsor

Leiden University Medical Center